119 related articles for article (PubMed ID: 3560190)
21. The variations of the serum IgD and of the circulant immune complexes in diabetic patients.
Cheţa D; Cojocaru M; Mogoş T; Iosif C; Cheţa N; Trifan E; Alexandrescu R; Halmagy I; Enache M
Rom J Intern Med; 1992; 30(1):57-62. PubMed ID: 1496260
[TBL] [Abstract][Full Text] [Related]
22. Circulating auto-antibodies in Ménière's disease.
Perez Garrigues H; Carmona E; Morera C; Sanchez-Cuenca JM
Ann Otolaryngol Chir Cervicofac; 1995; 112(5):225-8. PubMed ID: 7503502
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
24. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
[TBL] [Abstract][Full Text] [Related]
25. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of glomerulonephritis and autoantibodies in diabetes mellitus.
Bhuyan UN; Dash SC; Srikanta S; Malaviya AN; Malhotra KK
J Assoc Physicians India; 1984 Feb; 32(2):171-5. PubMed ID: 6235208
[No Abstract] [Full Text] [Related]
27. Platelet associated IgG (PA IgG) in patients with insulin dependent (type 1) diabetes mellitus.
Triolo G
J Clin Lab Immunol; 1988 Apr; 25(4):173-5. PubMed ID: 3172176
[TBL] [Abstract][Full Text] [Related]
28. [Circulating immune complexes in the blood of diabetics].
Podil'chak MD; Terletskaia LM; Podil'chak EM; Nevzgoda AA; Krasivs'kiĭ
Vrach Delo; 1984 Nov; (11):55-7. PubMed ID: 6528560
[No Abstract] [Full Text] [Related]
29. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
Sordi V; Lampasona V; Cainarca S; Bonifacio E
Diabet Med; 2005 Dec; 22(12):1770-3. PubMed ID: 16401328
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
Newkirk MM; LePage K; Niwa T; Rubin L
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
[TBL] [Abstract][Full Text] [Related]
32. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
33. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
34. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
35. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
36. [Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].
Efimov AS; Malyzhev VA; Sakalo EA
Ter Arkh; 1987; 59(11):15-8. PubMed ID: 3441859
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity and circulating immune complexes in retinal vasculitis.
Kasp-Grochowska E; Graham E; Sanders MD; Dumonde DC; Kozak Y; van Tuyen V; Faure JP
Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):342-8. PubMed ID: 6985101
[TBL] [Abstract][Full Text] [Related]
38. The content of immunoglobulins, auto-antibodies, myocardial antigen and immune complexes in patients with ischaemic heart disease in relationship to the state of circulation.
Baranovskii PV
Cor Vasa; 1986; 28(3):181-5. PubMed ID: 2427275
[TBL] [Abstract][Full Text] [Related]
39. [Complement (C3) receptor dependent monocyte recognition in uncompensated diabetes mellitus types I and II].
Gómez Rodríguez F; Ruiz Alcantarilla P; Zamora Madaria E
Rev Clin Esp; 1986 Sep; 179(4):167-71. PubMed ID: 3532232
[No Abstract] [Full Text] [Related]
40. [Circulating immune complexes in patients with diabetes type I and II].
Jabłońska E; Pietruska Z
Endokrynol Pol; 1993; 44(2):129-35. PubMed ID: 8055783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
